Skip to main content
Top
Published in: Trials 1/2014

Open Access 01-12-2014 | Study protocol

SMS reminders to improve the tuberculosis cure rate in developing countries (TB-SMS Cameroon): a protocol of a randomised control study

Authors: Georges Bediang, Beat Stoll, Nadia Elia, Jean-Louis Abena, Désiré Nolna, Philippe Chastonay, Antoine Geissbuhler

Published in: Trials | Issue 1/2014

Login to get access

Abstract

Background

Tuberculosis is a public health problem in Cameroon, just like in many other countries in the world. The National Tuberculosis Control Programme (PNLT) put in place by the state, aims to fight tuberculosis through the implementation of international directives (Directly Observed Treatment Short, DOTS). Despite the deployment of this strategy across the world, its implementation is difficult in the context of low-resource countries. Some expected results are not achieved. In Cameroon, the cure rate for patients with sputum positive pulmonary tuberculosis (TPM+) after 6 months is only about 65%, 20% below the target. This is mainly due to poor patient adherence to treatment. By relying on the potential of mobile Health, the objective of this study is to evaluate the effect of SMS reminders on the cure rate of TPM + patients, measured using 6-month bacilloscopy.

Methods/design

This is a blinded, randomised controlled multicentre study carried out in Cameroon. The research hypothesis is that sending daily SMS messages to remind patients to take their prescribed tuberculosis medication, together with the standard DOTS strategy, will increase the cure rate from 65% (control group: DOTS, no SMS intervention) to 85% (intervention group: DOTS, with SMS intervention) in a group of new TPM + patients. In accordance with each treatment centre, the participants will be randomly allocated into the two groups using a computer program: the intervention group and the control group. A member of the research team will send daily SMS messages. Study data will be collected by health professionals involved in the care of patients. Data analysis will be done by the intention-to-treat method.

Discussion

The achieving of expected outcomes by the PNLT through implementation of DOTS requires several challenges. Although it has been demonstrated that the DOTS strategy is effective in the fight against tuberculosis, its application remains difficult in developing countries. This study explores the potential of mHealth to support DOTS strategy. It will gather new evidence on the effectiveness of mHealth-based interventions and SMS reminders in the improvement of treatment adherence and the cure rate of tuberculosis patients, especially in a low-resource country such as Cameroon.

Trial registration

The trial is registered on the Pan-African Clinical Trials Registry (http://​www.​pactr.​org) under unique identification number: PACTR201307000583416.
Appendix
Available only for authorised users
Literature
1.
go back to reference Programme National de Lutte contre la Tuberculose au Cameroun: Guide technique pour les personnels de santé. 2011, Ministry of Public Health of Cameroon Programme National de Lutte contre la Tuberculose au Cameroun: Guide technique pour les personnels de santé. 2011, Ministry of Public Health of Cameroon
4.
go back to reference World Health Organisation: Plan mondial halte à la tuberculose 2006–2015: agir pour la vie, vers un monde sans tuberculose (WHO/HTM/STB/2006.35). 2006, Geneva World Health Organisation: Plan mondial halte à la tuberculose 2006–2015: agir pour la vie, vers un monde sans tuberculose (WHO/HTM/STB/2006.35). 2006, Geneva
5.
go back to reference World Health Organisation: Plan mondial halte à la tuberculose. 2011, –2015 World Health Organisation: Plan mondial halte à la tuberculose. 2011, –2015
6.
go back to reference Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X: Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008, CD000011- Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X: Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008, CD000011-
7.
go back to reference Ongugo K, Hall J, Attia J: Implementing tuberculosis control in Papua New Guinea: a clash of culture and science?. J Community Health. 2011, 36: 423-430.CrossRefPubMed Ongugo K, Hall J, Attia J: Implementing tuberculosis control in Papua New Guinea: a clash of culture and science?. J Community Health. 2011, 36: 423-430.CrossRefPubMed
8.
go back to reference Volmink J, Garner P: Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2011 Volmink J, Garner P: Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2011
9.
go back to reference M'Imunya JM, Kredo T, Volmink J: Patient education and counselling for promoting adherence to treatment for tuberculosis (review). Cochrane Library. 2012, CD006591- M'Imunya JM, Kredo T, Volmink J: Patient education and counselling for promoting adherence to treatment for tuberculosis (review). Cochrane Library. 2012, CD006591-
10.
go back to reference Ormerod LP, Prescott RJ: Inter-relations between relapses, drug regimens and compliance with treatment in tuberculosis. Respir Med. 1991, 85: 239-242.CrossRefPubMed Ormerod LP, Prescott RJ: Inter-relations between relapses, drug regimens and compliance with treatment in tuberculosis. Respir Med. 1991, 85: 239-242.CrossRefPubMed
11.
go back to reference Weis SE, Slocum PC, Blais FX, King B, Nunn M, Matney GB, Gomez E, Foresman BH: The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med. 1994, 330: 1179-1184.CrossRefPubMed Weis SE, Slocum PC, Blais FX, King B, Nunn M, Matney GB, Gomez E, Foresman BH: The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med. 1994, 330: 1179-1184.CrossRefPubMed
12.
go back to reference Mitchison DA: How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis. 1998, 2: 10-15.PubMed Mitchison DA: How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis. 1998, 2: 10-15.PubMed
13.
go back to reference Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR: Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med. 1993, 328: 527-532.CrossRefPubMed Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR: Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med. 1993, 328: 527-532.CrossRefPubMed
14.
go back to reference Liu Q, Abba K, Alejandria MM, Balanag VM, Berba RP, Lansang MA: Reminder systems and late patient tracers in the diagnosis and management of tuberculosis. Cochrane Database Syst Rev. 2008, CD006594- Liu Q, Abba K, Alejandria MM, Balanag VM, Berba RP, Lansang MA: Reminder systems and late patient tracers in the diagnosis and management of tuberculosis. Cochrane Database Syst Rev. 2008, CD006594-
15.
go back to reference WHO Global Observatory for e-Health: mHealth: new horizons for health through mobile technologies. Second Global Survey on Health. 2011, 3: 1-103. Global Observatory for eHealth WHO Global Observatory for e-Health: mHealth: new horizons for health through mobile technologies. Second Global Survey on Health. 2011, 3: 1-103. Global Observatory for eHealth
16.
go back to reference Person AK, Blain ML, Jiang H, Rasmussen PW, Stout JE: Text messaging for enhancement of testing and treatment for tuberculosis, human immunodeficiency virus, and syphilis: a survey of attitudes toward cellular phones and healthcare. Telemed J E Health. 2011, 17: 189-195.CrossRefPubMedPubMedCentral Person AK, Blain ML, Jiang H, Rasmussen PW, Stout JE: Text messaging for enhancement of testing and treatment for tuberculosis, human immunodeficiency virus, and syphilis: a survey of attitudes toward cellular phones and healthcare. Telemed J E Health. 2011, 17: 189-195.CrossRefPubMedPubMedCentral
17.
go back to reference Mukund Bahadur KC, Murray PJ: Cell phone short messaging service (SMS) for HIV/AIDS in South Africa: a literature review. Stud Health Technol Inform. 2010, 160: 530-534.PubMed Mukund Bahadur KC, Murray PJ: Cell phone short messaging service (SMS) for HIV/AIDS in South Africa: a literature review. Stud Health Technol Inform. 2010, 160: 530-534.PubMed
18.
go back to reference Krishna S, Boren SA, Balas EA: Healthcare via cell phones: a systematic review. Telemed J E Health. 2009, 15: 231-240.CrossRefPubMed Krishna S, Boren SA, Balas EA: Healthcare via cell phones: a systematic review. Telemed J E Health. 2009, 15: 231-240.CrossRefPubMed
19.
go back to reference Mahmud N, Rodriguez J, Nesbit J: A text message-based intervention to bridge the healthcare communication gap in the rural developing world. Technol Health Care. 2010, 18: 137-144.PubMed Mahmud N, Rodriguez J, Nesbit J: A text message-based intervention to bridge the healthcare communication gap in the rural developing world. Technol Health Care. 2010, 18: 137-144.PubMed
20.
go back to reference Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lester RT, Mills E, Volmink, Yondo D, Essi MJ, Bonono-Momnougui RC, Mba R, Ndongo JS, Nkoa FC, Ondoa HA: The Cameroon mobile phone SMS (CAMPS) trial: a protocol for a randomized controlled trial of mobile phone text messaging versus usual care for improving adherence to highly active anti-retroviral therapy. Trials. 2011, 12: 5-CrossRefPubMedPubMedCentral Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lester RT, Mills E, Volmink, Yondo D, Essi MJ, Bonono-Momnougui RC, Mba R, Ndongo JS, Nkoa FC, Ondoa HA: The Cameroon mobile phone SMS (CAMPS) trial: a protocol for a randomized controlled trial of mobile phone text messaging versus usual care for improving adherence to highly active anti-retroviral therapy. Trials. 2011, 12: 5-CrossRefPubMedPubMedCentral
21.
go back to reference De CA, Shet A, Kumarasamy N, Ashorn P, Eriksson B, Bogg L, Diwan VK: Design of a randomized trial to evaluate the influence of mobile phone reminders on adherence to first line antiretroviral treatment in South India – the HIVIND study protocol. BMC Med Res Methodol. 2010, 10: 25-CrossRef De CA, Shet A, Kumarasamy N, Ashorn P, Eriksson B, Bogg L, Diwan VK: Design of a randomized trial to evaluate the influence of mobile phone reminders on adherence to first line antiretroviral treatment in South India – the HIVIND study protocol. BMC Med Res Methodol. 2010, 10: 25-CrossRef
22.
go back to reference Lester RT, Mills EJ, Kariri A, Ritvo P, Chung M, Jack W, Habyarimana J, Karanja S, Barasa S, Nguti R, Estambale B, Ngugi E, Ball TB, Thabane L, Kimanai J, Gelmon L, Ackers M, Plummer FA: The HAART cell phone adherence trial (WelTel Kenya1): a randomized controlled trial protocol. Trials. 2009, 10: 87-CrossRefPubMedPubMedCentral Lester RT, Mills EJ, Kariri A, Ritvo P, Chung M, Jack W, Habyarimana J, Karanja S, Barasa S, Nguti R, Estambale B, Ngugi E, Ball TB, Thabane L, Kimanai J, Gelmon L, Ackers M, Plummer FA: The HAART cell phone adherence trial (WelTel Kenya1): a randomized controlled trial protocol. Trials. 2009, 10: 87-CrossRefPubMedPubMedCentral
23.
go back to reference Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, Jack W, Habyarimana J, Sadatsafavi M, Najafzadeh M, Marra CA, Estambale B, Ngugi E, Ball TB, Thabane L, Gelmon LJ, Kimani J, Ackers M, Plummer FA: Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010, 376: 1838-1845.CrossRefPubMed Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, Jack W, Habyarimana J, Sadatsafavi M, Najafzadeh M, Marra CA, Estambale B, Ngugi E, Ball TB, Thabane L, Gelmon LJ, Kimani J, Ackers M, Plummer FA: Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010, 376: 1838-1845.CrossRefPubMed
24.
go back to reference Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, De WD, Mackeen L, Haberer J, Kimaiyo S, Sidle J, Ngare D, Bangsberg DR: Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011, 25: 825-834.CrossRefPubMedPubMedCentral Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, De WD, Mackeen L, Haberer J, Kimaiyo S, Sidle J, Ngare D, Bangsberg DR: Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011, 25: 825-834.CrossRefPubMedPubMedCentral
25.
go back to reference Dean AL, Makin JD, Kydd AS, Biriotti M, Forsyth BW: A pilot study using interactive SMS support groups to prevent mother-to-child HIV transmission in South Africa. J Telemed Telecare. 2012, 18: 399-403.CrossRefPubMed Dean AL, Makin JD, Kydd AS, Biriotti M, Forsyth BW: A pilot study using interactive SMS support groups to prevent mother-to-child HIV transmission in South Africa. J Telemed Telecare. 2012, 18: 399-403.CrossRefPubMed
26.
go back to reference Zurovac D, Sudoi RK, Akhwale WS, Ndiritu M, Hamer DH, Rowe AK, Snow RW: The effect of mobile phone text-message reminders on Kenyan health workers' adherence to malaria treatment guidelines: a cluster randomised trial. Lancet. 2011, 378: 795-803.CrossRefPubMedPubMedCentral Zurovac D, Sudoi RK, Akhwale WS, Ndiritu M, Hamer DH, Rowe AK, Snow RW: The effect of mobile phone text-message reminders on Kenyan health workers' adherence to malaria treatment guidelines: a cluster randomised trial. Lancet. 2011, 378: 795-803.CrossRefPubMedPubMedCentral
27.
go back to reference Moonen B, Cohen JM: Text messaging to improve adherence to malaria guidelines. Lancet. 2011, 378: 750-752.CrossRefPubMed Moonen B, Cohen JM: Text messaging to improve adherence to malaria guidelines. Lancet. 2011, 378: 750-752.CrossRefPubMed
29.
go back to reference Barrington J, Wereko-Brobby O, Ward P, Mwafongo W, Kungulwe S: SMS for Life: a pilot project to improve anti-malarial drug supply management in rural Tanzania using standard technology. Malar J. 2010, 9: 298-CrossRefPubMedPubMedCentral Barrington J, Wereko-Brobby O, Ward P, Mwafongo W, Kungulwe S: SMS for Life: a pilot project to improve anti-malarial drug supply management in rural Tanzania using standard technology. Malar J. 2010, 9: 298-CrossRefPubMedPubMedCentral
30.
go back to reference Chen TC, Lin WR, Lu PL, Lin CY, Lin SH, Lin CJ, Feng MC, Chiang HC, Chen YH, Huang MS: Computer laboratory notification system via short message service to reduce health care delays in management of tuberculosis in Taiwan. Am J Infect Control. 2011, 39: 426-430.CrossRefPubMed Chen TC, Lin WR, Lu PL, Lin CY, Lin SH, Lin CJ, Feng MC, Chiang HC, Chen YH, Huang MS: Computer laboratory notification system via short message service to reduce health care delays in management of tuberculosis in Taiwan. Am J Infect Control. 2011, 39: 426-430.CrossRefPubMed
31.
go back to reference Zimic M, Coronel J, Gilman RH, Luna CG, Curioso WH, Moore DA: Can the power of mobile phones be used to improve tuberculosis diagnosis in developing countries?. Trans R Soc Trop Med Hyg. 2009, 103: 638-640.CrossRefPubMed Zimic M, Coronel J, Gilman RH, Luna CG, Curioso WH, Moore DA: Can the power of mobile phones be used to improve tuberculosis diagnosis in developing countries?. Trans R Soc Trop Med Hyg. 2009, 103: 638-640.CrossRefPubMed
32.
go back to reference Hüsler J: Evaluation of the On Cue Compliance Service Pilot. Testing the Use of SMS Reminders in the Treatment of Tuberculosis in Cape Town. 2005, South Africa: Technology Associate, bridges.org, City of Cape Town Health Directorate and the International Development Research Council (IDRC) Hüsler J: Evaluation of the On Cue Compliance Service Pilot. Testing the Use of SMS Reminders in the Treatment of Tuberculosis in Cape Town. 2005, South Africa: Technology Associate, bridges.org, City of Cape Town Health Directorate and the International Development Research Council (IDRC)
34.
go back to reference Amico KR, Fisher WA, Cornman DH, Shuper PA, Redding CG, Konkle-Parker DJ, Barta W, Fisher JD: Visual analog scale of ART adherence: association with 3-day self-report and adherence barriers. J Acquir Immune Defic Syndr. 2006, 42: 455-459.CrossRefPubMed Amico KR, Fisher WA, Cornman DH, Shuper PA, Redding CG, Konkle-Parker DJ, Barta W, Fisher JD: Visual analog scale of ART adherence: association with 3-day self-report and adherence barriers. J Acquir Immune Defic Syndr. 2006, 42: 455-459.CrossRefPubMed
35.
go back to reference Peltzer K, Friend-du PN, Ramlagan S, Anderson J: Antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa. BMC Public Health. 2010, 10: 111-CrossRefPubMedPubMedCentral Peltzer K, Friend-du PN, Ramlagan S, Anderson J: Antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa. BMC Public Health. 2010, 10: 111-CrossRefPubMedPubMedCentral
36.
go back to reference Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR: Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004, 5: 74-79.CrossRefPubMed Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR: Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004, 5: 74-79.CrossRefPubMed
37.
go back to reference Maneesriwongul WL, Tulathong S, Fennie KP, Williams AB: Adherence to antiretroviral medication among HIV-positive patients in Thailand. J Acquir Immune Defic Syndr. 2006, 43 (Suppl 1): S119-S122.CrossRefPubMed Maneesriwongul WL, Tulathong S, Fennie KP, Williams AB: Adherence to antiretroviral medication among HIV-positive patients in Thailand. J Acquir Immune Defic Syndr. 2006, 43 (Suppl 1): S119-S122.CrossRefPubMed
38.
go back to reference Arnsten JH, Demas PA, Farzadegan H, Grant RW, Gourevitch MN, Chang CJ, Buono D, Eckholdt H, Howard AA, Schoenbaum EE: Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001, 33: 1417-1423.CrossRefPubMedPubMedCentral Arnsten JH, Demas PA, Farzadegan H, Grant RW, Gourevitch MN, Chang CJ, Buono D, Eckholdt H, Howard AA, Schoenbaum EE: Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001, 33: 1417-1423.CrossRefPubMedPubMedCentral
40.
go back to reference Schulz KF, Altman DG, Moher D: CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2011, 9: 672-677.CrossRefPubMed Schulz KF, Altman DG, Moher D: CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2011, 9: 672-677.CrossRefPubMed
41.
go back to reference World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. Nurs Ethics. 2002, 9: 105-109.CrossRef World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. Nurs Ethics. 2002, 9: 105-109.CrossRef
44.
go back to reference Ibrahim KM, Khan S, Laaser U: Tuberculosis control: current status, challenges and barriers ahead in 22 high endemic countries. J Ayub Med Coll Abbottabad. 2002, 14: 11-15.PubMed Ibrahim KM, Khan S, Laaser U: Tuberculosis control: current status, challenges and barriers ahead in 22 high endemic countries. J Ayub Med Coll Abbottabad. 2002, 14: 11-15.PubMed
45.
go back to reference Borgdorff MW, Floyd K, Broekmans JF: Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries. Bull World Health Organ. 2002, 80: 217-227.PubMedPubMedCentral Borgdorff MW, Floyd K, Broekmans JF: Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries. Bull World Health Organ. 2002, 80: 217-227.PubMedPubMedCentral
Metadata
Title
SMS reminders to improve the tuberculosis cure rate in developing countries (TB-SMS Cameroon): a protocol of a randomised control study
Authors
Georges Bediang
Beat Stoll
Nadia Elia
Jean-Louis Abena
Désiré Nolna
Philippe Chastonay
Antoine Geissbuhler
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Trials / Issue 1/2014
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-15-35

Other articles of this Issue 1/2014

Trials 1/2014 Go to the issue